{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:15:09Z","timestamp":1789604109471,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2013,11,8]],"date-time":"2013-11-08T00:00:00Z","timestamp":1383868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,11,8]],"date-time":"2013-11-08T00:00:00Z","timestamp":1383868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1038\/cgt.2013.67","type":"journal-article","created":{"date-parts":[[2013,11,8]],"date-time":"2013-11-08T11:13:43Z","timestamp":1383909223000},"page":"671-677","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Highly efficient tumor transduction and antitumor efficacy in experimental human malignant mesothelioma using replicating gibbon ape leukemia virus"],"prefix":"10.1038","volume":"20","author":[{"given":"S","family":"Kubo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Takagi-Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C R","family":"Logg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Kasahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,11,8]]},"reference":[{"key":"BFcgt201367_CR1","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1177\/107327480601300402","volume":"13","author":"R Ismail-Khan","year":"2006","unstructured":"Ismail-Khan R, Robinson LA, Williams CC Jr, Garrett CR, Bepler G, Simon GR . Malignant pleural mesothelioma: a comprehensive review. Cancer Control 2006; 13: 255\u2013263.","journal-title":"Cancer Control"},{"key":"BFcgt201367_CR2","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1200\/JCO.2008.19.8523","volume":"27","author":"AS Tsao","year":"2009","unstructured":"Tsao AS, Wistuba I, Roth JA, Kindler HL . Malignant pleural mesothelioma. J Clin Oncol 2009; 27: 2081\u20132090.","journal-title":"J Clin Oncol"},{"key":"BFcgt201367_CR3","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/sj.cgt.7700935","volume":"13","author":"RG van der Most","year":"2006","unstructured":"van der Most RG, Robinson BW, Nelson DJ . Gene therapy for malignant mesothelioma: beyond the infant years. Cancer Gene Ther 2006; 13: 897\u2013904.","journal-title":"Cancer Gene Ther"},{"key":"BFcgt201367_CR4","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0272-5231(03)00072-8","volume":"23","author":"SM Albelda","year":"2002","unstructured":"Albelda SM, Wiewrodt R, Sterman DH . Gene therapy for lung neoplasms. Clin Chest Med 2002; 23: 265\u2013277.","journal-title":"Clin Chest Med"},{"key":"BFcgt201367_CR5","doi-asserted-by":"publisher","first-page":"7444","DOI":"10.1158\/1078-0432.CCR-05-0405","volume":"11","author":"DH Sterman","year":"2005","unstructured":"Sterman DH, Recio A, Vachani A, Sun J, Cheung L, DeLong P et al. Long-term follow-up of patients with malignant pleural mesothelioma receiving high-dose adenovirus herpes simplex thymidine kinase\/ganciclovir suicide gene therapy. Clin Cancer Res 2005; 11: 7444\u20137453.","journal-title":"Clin Cancer Res"},{"key":"BFcgt201367_CR6","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1089\/hum.1998.9.7-1083","volume":"9","author":"DH Sterman","year":"1998","unstructured":"Sterman DH, Treat J, Litzky LA, Amin KM, Coonrod L, Molnar-Kimber K et al. Adenovirus-mediated herpes simplex virus thymidine kinase\/ganciclovir gene therapy in patients with localized malignancy: results of a phase I clinical trial in malignant mesothelioma. Hum Gene Ther 1998; 9: 1083\u20131092.","journal-title":"Hum Gene Ther"},{"key":"BFcgt201367_CR7","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/77283","volume":"18","author":"R Alemany","year":"2000","unstructured":"Alemany R, Balague C, Curiel DT . Replicative adenoviruses for cancer therapy. Nat Biotechnol 2000; 18: 723\u2013727.","journal-title":"Nat Biotechnol"},{"key":"BFcgt201367_CR8","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/gt.2008.72","volume":"15","author":"TC Liu","year":"2008","unstructured":"Liu TC, Kirn D . Gene therapy progress and prospects cancer: oncolytic viruses. Gene Ther 2008; 15: 877\u2013884.","journal-title":"Gene Ther"},{"key":"BFcgt201367_CR9","doi-asserted-by":"publisher","first-page":"7120","DOI":"10.1158\/0008-5472.CAN-08-0047","volume":"68","author":"T Fukazawa","year":"2008","unstructured":"Fukazawa T, Matsuoka J, Naomoto Y, Maeda Y, Durbin ML, Tanaka N . Malignant pleural mesothelioma-targeted CREBBP\/EP300 inhibitory protein 1 promoter system for gene therapy and virotherapy. Cancer Res 2008; 68: 7120\u20137129.","journal-title":"Cancer Res"},{"key":"BFcgt201367_CR10","first-page":"701","volume":"1","author":"ZB Zhu","year":"2006","unstructured":"Zhu ZB, Makhija SK, Lu B, Wang M, Wang S, Takayama K et al. Targeting mesothelioma using an infectivity enhanced survivin-conditionally replicative adenoviruses. J Thorac Oncol 2006; 1: 701\u2013711.","journal-title":"J Thorac Oncol"},{"key":"BFcgt201367_CR11","doi-asserted-by":"publisher","first-page":"3791","DOI":"10.1158\/1078-0432.CCR-08-3236","volume":"15","author":"P Brader","year":"2009","unstructured":"Brader P, Kelly KJ, Chen N, Yu YA, Zhang Q, Zanzonico P et al. Imaging a Genetically Engineered Oncolytic Vaccinia Virus (GLV-1h99) Using a Human Norepinephrine Transporter Reporter Gene. Clin Cancer Res 2009; 15: 3791\u20133801.","journal-title":"Clin Cancer Res"},{"key":"BFcgt201367_CR12","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1002\/jgm.877","volume":"8","author":"PS Adusumilli","year":"2006","unstructured":"Adusumilli PS, Stiles BM, Chan MK, Mullerad M, Eisenberg DP, Ben-Porat L et al. Imaging and therapy of malignant pleural mesothelioma using replication-competent herpes simplex viruses. J Gene Med 2006; 8: 603\u2013615.","journal-title":"J Gene Med"},{"key":"BFcgt201367_CR13","doi-asserted-by":"publisher","first-page":"7713","DOI":"10.1158\/0008-5472.CAN-09-1013","volume":"69","author":"CL Willmon","year":"2009","unstructured":"Willmon CL, Saloura V, Fridlender ZG, Wongthida P, Diaz RM, Thompson J et al. Expression of IFN-beta enhances both efficacy and safety of oncolytic vesicular stomatitis virus for therapy of mesothelioma. Cancer Res 2009; 69: 7713\u20137720.","journal-title":"Cancer Res"},{"key":"BFcgt201367_CR14","doi-asserted-by":"publisher","first-page":"4239","DOI":"10.1128\/MCB.10.8.4239","volume":"10","author":"DG Miller","year":"1990","unstructured":"Miller DG, Adam MA, Miller AD . Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection. Mol Cell Biol 1990; 10: 4239\u20134242.","journal-title":"Mol Cell Biol"},{"key":"BFcgt201367_CR15","doi-asserted-by":"publisher","first-page":"5345","DOI":"10.1158\/0008-5472.CAN-06-4673","volume":"67","author":"K Hiraoka","year":"2007","unstructured":"Hiraoka K, Kimura T, Logg CR, Tai CK, Haga K, Lawson GW et al. Therapeutic efficacy of replication-competent retrovirus vector-mediated suicide gene therapy in a multifocal colorectal cancer metastasis model. Cancer Res 2007; 67: 5345\u20135353.","journal-title":"Cancer Res"},{"issue":"15 Pt 1","key":"BFcgt201367_CR16","doi-asserted-by":"publisher","first-page":"4511","DOI":"10.1158\/1078-0432.CCR-07-0151","volume":"13","author":"E Kikuchi","year":"2007","unstructured":"Kikuchi E, Menendez S, Ozu C, Ohori M, Cordon-Cardo C, Logg CR et al. Highly efficient gene delivery for bladder cancers by intravesically administered replication-competent retroviral vectors. Clin Cancer Res 2007; 13 (15 Pt 1): 4511\u20134518.","journal-title":"Clin Cancer Res"},{"key":"BFcgt201367_CR17","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.ymthe.2005.03.017","volume":"12","author":"CK Tai","year":"2005","unstructured":"Tai CK, Wang WJ, Chen TC, Kasahara N . Single-shot, multicycle suicide gene therapy by replication-competent retrovirus vectors achieves long-term survival benefit in experimental glioma. Mol Ther 2005; 12: 842\u2013851.","journal-title":"Mol Ther"},{"key":"BFcgt201367_CR18","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1089\/104303403321070810","volume":"14","author":"WJ Wang","year":"2003","unstructured":"Wang WJ, Tai CK, Kasahara N, Chen TC . Highly efficient and tumor-restricted gene transfer to malignant gliomas by replication-competent retroviral vectors. Hum Gene Ther 2003; 14: 117\u2013127.","journal-title":"Hum Gene Ther"},{"key":"BFcgt201367_CR19","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/cgt.2011.25","volume":"18","author":"Y Kawasaki","year":"2011","unstructured":"Kawasaki Y, Tamamoto A, Takagi-Kimura M, Maeyama Y, Yamaoka N, Terada N et al. Replication-competent retrovirus vector-mediated prodrug activator gene therapy in experimental models of human malignant mesothelioma. Cancer Gene Ther 2011; 18: 571\u2013578.","journal-title":"Cancer Gene Ther"},{"key":"BFcgt201367_CR20","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.jmb.2007.04.026","volume":"369","author":"CR Logg","year":"2007","unstructured":"Logg CR, Baranick BT, Lemp NA, Kasahara N . Adaptive evolution of a tagged chimeric gammaretrovirus: identification of novel cis-acting elements that modulate splicing. J Mol Biol 2007; 369: 1214\u20131229.","journal-title":"J Mol Biol"},{"key":"BFcgt201367_CR21","doi-asserted-by":"crossref","first-page":"5564","DOI":"10.1128\/jvi.70.8.5564-5571.1996","volume":"70","author":"AD Miller","year":"1996","unstructured":"Miller AD, Chen F . Retrovirus packaging cells based on 10A1 murine leukemia virus for production of vectors that use multiple receptors for cell entry. J Virol 1996; 70: 5564\u20135571.","journal-title":"J Virol"},{"key":"BFcgt201367_CR22","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1128\/MMBR.65.3.371-389.2001","volume":"65","author":"J Overbaugh","year":"2001","unstructured":"Overbaugh J, Miller AD, Eiden MV . Receptors and entry cofactors for retroviruses include single and multiple transmembrane-spanning proteins as well as newly described glycophosphatidylinositol-anchored and secreted proteins. Microbiol Mol Biol Rev 2001; 65: 371\u2013389 table of contents.","journal-title":"Microbiol Mol Biol Rev"},{"key":"BFcgt201367_CR23","first-page":"769","volume":"25","author":"YC Lu","year":"2011","unstructured":"Lu YC, Luo YP, Wang YW, Tai CK . Highly efficient gene transfer to solid tumors in vivo by tumor-selective replicating retrovirus vectors. Int J Mol Med 2011; 25: 769\u2013775.","journal-title":"Int J Mol Med"},{"key":"BFcgt201367_CR24","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1089\/104303401750195881","volume":"12","author":"CR Logg","year":"2001","unstructured":"Logg CR, Tai CK, Logg A, Anderson WF, Kasahara N . A uniquely stable replication-competent retrovirus vector achieves efficient gene delivery in vitro and in solid tumors. Hum Gene Ther 2001; 12: 921\u2013932.","journal-title":"Hum Gene Ther"},{"key":"BFcgt201367_CR25","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1089\/104303403765255174","volume":"14","author":"CK Tai","year":"2003","unstructured":"Tai CK, Logg CR, Park JM, Anderson WF, Press MF, Kasahara N . Antibody-mediated targeting of replication-competent retroviral vectors. Human Gene Ther 2003; 14: 789\u2013802.","journal-title":"Human Gene Ther"},{"key":"BFcgt201367_CR26","doi-asserted-by":"publisher","first-page":"8036","DOI":"10.1073\/pnas.0601954103","volume":"103","author":"S Kubo","year":"2006","unstructured":"Kubo S, Seleme MC, Soifer HS, Perez JL, Moran JV, Kazazian HH Jr. et al. L1 retrotransposition in nondividing and primary human somatic cells. Proc Natl Acad Sci USA 2006; 103: 8036\u20138041.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFcgt201367_CR27","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1128\/JVI.77.5.2964-2971.2003","volume":"77","author":"S Kubo","year":"2003","unstructured":"Kubo S, Mitani K . A new hybrid system capable of efficient lentiviral vector production and stable gene transfer mediated by a single helper-dependent adenoviral vector. J Virol 2003; 77: 2964\u20132971.","journal-title":"J Virol"},{"key":"BFcgt201367_CR28","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/jgm.1486","volume":"12","author":"S Kubo","year":"2010","unstructured":"Kubo S, Kawasaki Y, Yamaoka N, Tagawa M, Kasahara N, Terada N et al. Complete regression of human malignant mesothelioma xenografts following local injection of midkine promoter-driven oncolytic adenovirus. J Gene Med 2010; 12: 681\u2013692.","journal-title":"J Gene Med"},{"key":"BFcgt201367_CR29","first-page":"273","volume":"37","author":"N Yamaoka","year":"2010","unstructured":"Yamaoka N, Kawasaki Y, Xu Y, Yamamoto H, Terada N, Okamura H et al. Establishment of in vivo fluorescence imaging in mouse models of malignant mesothelioma. Int J Oncol 2010; 37: 273\u2013279.","journal-title":"Int J Oncol"},{"key":"BFcgt201367_CR30","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/mt.2010.182","volume":"19","author":"S Kubo","year":"2011","unstructured":"Kubo S, Haga K, Tamamoto A, Palmer DJ, Ng P, Okamura H et al. Adenovirus-retrovirus hybrid vectors achieve highly enhanced tumor transduction and antitumor efficacy in vivo. Mol Ther 2011; 19: 76\u201382.","journal-title":"Mol Ther"},{"key":"BFcgt201367_CR31","doi-asserted-by":"publisher","first-page":"189","DOI":"10.2174\/156652307780859062","volume":"7","author":"SK Campos","year":"2007","unstructured":"Campos SK, Barry MA . Current advances and future challenges in Adenoviral vector biology and targeting. Curr Gene Ther 2007; 7: 189\u2013204.","journal-title":"Curr Gene Ther"},{"key":"BFcgt201367_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/1566523044577997","volume":"4","author":"JN Glasgow","year":"2004","unstructured":"Glasgow JN, Bauerschmitz GJ, Curiel DT, Hemminki A . Transductional and transcriptional targeting of adenovirus for clinical applications. Curr Gene Ther 2004; 4: 1\u201314.","journal-title":"Curr Gene Ther"},{"key":"BFcgt201367_CR33","doi-asserted-by":"publisher","first-page":"12783","DOI":"10.1128\/JVI.76.24.12783-12791.2002","volume":"76","author":"CR Logg","year":"2002","unstructured":"Logg CR, Logg A, Matusik RJ, Bochner BH, Kasahara N . Tissue-specific transcriptional targeting of a replication-competent retroviral vector. J Virol 2002; 76: 12783\u201312791.","journal-title":"J Virol"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/cgt201367.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cgt201367","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/cgt201367.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,19]],"date-time":"2024-05-19T08:55:57Z","timestamp":1716108957000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/cgt201367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,8]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["BFcgt201367"],"URL":"https:\/\/doi.org\/10.1038\/cgt.2013.67","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,11,8]]},"assertion":[{"value":"25 August 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"CRL and NK are paid consultants to Tocagen Inc.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}